Sign In
Free Newsletter
Tevogen CEO funds expanded Warren HQ
Dr. Ryan Saadi provided $500,000 for the build-out and first-year operating costs of the facility, which was completed ahead of schedule.
Tevogen Bio doubles Warren HQ footprint for AI expansion
The new lease agreement will enable the biotech to centralize its teams and support artificial intelligence-powered drug discovery and biosimilar initiatives.
Biotech Tevogen secures up to $10M in grant funding
The Warren-headquartered clinical-stage specialty immunotherapy biotechnology company focuses on the development of T-cell therapeutics that address the significant unmet needs of large patient populations for treatments of cancer.
Tevogen Bio providing new hope for COVID patients
2024 has been an active year for Warren-based Tevogen Bio, a clinical-stage specialty immunotherapy company that is using innovation to develop affordable personalized treatments for large patient populations.
Tevogen Bio taps award-winning oncologist to lead R&D
The Warren-based biotech company named Dr. Neal Flomenberg as chief scientific officer and global head of research and development.
Warren-based biotech company opens R&D facility in Philly
Tevogen Bio launched the Research and Development Center in the city's historic Wanamaker building with the goal of expanding its precision T cell product pipeline in oncology, neurology and virology.
Biopharma firm Tevogen Bio opens new office in I-78 corridor
Company executives said New Jersey was selected because of its “Medicine Chest of the World” status.
